Dornase alfa
Brand names,
Dornase alfa
Analogs
Dornase alfa
Brand Names Mixture
Dornase alfa
Chemical_Formula
C1321H1999N339O396S9
Dornase alfa
RX_link
http://www.rxlist.com/cgi/generic3/pulmozyme.htm
Dornase alfa
fda sheet
Dornase alfa
msds (material safety sheet)
Dornase alfa
Synthesis Reference
No information avaliable
Dornase alfa
Molecular Weight
29253.9
Dornase alfa
Melting Point
67 oC (Chan, H.K. et al., Pharm Res. 13:756-761 (1996))
Dornase alfa
H2O Solubility
No information avaliable
Dornase alfa
State
Liquid
Dornase alfa
LogP
-0.083
Dornase alfa
Dosage Forms
Solution
Dornase alfa
Indication
For treatment of cystic fibrosis
Dornase alfa
Pharmacology
Cystic fibrosis (CF) is a disease characterized by the retention of viscous purulent secretions in the airways. These thick secretions contribute both to reduced pulmonary function and to frequent pulmonary infection. Purulent pulmonary secretions contain very high concentrations of extracellular DNA released by degenerating leukocytes that accumulate in response to these infections. Pulmozyme hydrolyzes the DNA in sputum of CF patients and reduces sputum viscoelasticity.
Dornase alfa
Absorption
No information avaliable
Dornase alfa
side effects and Toxicity
No information avaliable
Dornase alfa
Patient Information
BIOD00001.html
Dornase alfa
Organisms Affected
Humans and other mammals